Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia

ClinicalTrials.gov ID: NCT01227512

Public ClinicalTrials.gov record NCT01227512. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia

Study identification

NCT ID
NCT01227512
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
124 participants

Conditions and interventions

Interventions

  • tolvaptan Drug
  • Fluid Restriction Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2010
Primary completion
Apr 30, 2013
Completion
Apr 30, 2013
Last update posted
Oct 29, 2014

2010 – 2013

United States locations

U.S. sites
56
U.S. states
23
U.S. cities
49
Facility City State ZIP Site status
Otsuka Investigational Site Birmingham Alabama 35216
Otsuka Investigational Site Birmingham Alabama 35242
Otsuka Investigational Site Mobile Alabama 36608
Otsuka Investigational Site Azusa California 91702
Otsuka Investigational Site Banning California 92220
Otsuka Investigational Site Culver City California 90232
Otsuka Investigational Site Fountain Valley California 92708
Otsuka Investigational Site Los Angeles California 90025
Otsuka Investigational Site Los Angeles California 90033
Otsuka Investigational Site Northridge California 91324
Otuska Investigational Site Orange California 92868
Otsuka Investigational Site Yorba Linda California 92886
Otsuka Investigational Site Denver Colorado 80210
Otsuka Investigational Site Washington D.C. District of Columbia 20010
Otsuka Investigational Site Jacksonville Florida 32207
Otsuka Investigational Site Jacksonville Florida 32209
Otsuka Investigational Site Jacksonville Florida 32216
Otsuka Investigational Site Orlando Florida 32803
Otsuka Investigational Site Port Charlotte Florida 33952
Otsuka Investigational Site Savannah Georgia 31405
Otsuka Investigational Site Elizabethtown Kentucky 42701
Otsuka Investigational Site Baltimore Maryland 21215
Otsuka Investigational Site Springfield Massachusetts 01107
Otsuka Investigational Site Saginaw Michigan 48602
Otsuka Investigational Site Southfield Michigan 48075
Otsuka Investigational Site Minneapolis Minnesota 55455
Otsuka Investigational Site Rochester Minnesota 55905
Otsuka Investigational Site Jackson Mississippi 39216
Otsuka Investigational Site St Louis Missouri 63110
Otsuka Investigational Site Grand Island Nebraska 68803
Otsuka Investigational Site Omaha Nebraska 68131
Otsuka Investigational Site Haddon Heights New Jersey 08035
Otsuka Investigational Site Newark New Jersey 07103
Otsuka Investigational Site Buffalo New York 14203
Otsuka Investigational Site Buffalo New York 14215
Otsuka Investigational Site Jamaica New York 11418
Otsuka Investigational Site New York New York 10032
Otsuka Investigational Site The Bronx New York 10461
Otsuka Investigational Site Cincinnati Ohio 45267
Otsuka Investigational Site Cleveland Ohio 44195
Otsuka Investigational Site Columbus Ohio 43212
Otsuka Investigational Site Fairfield Ohio 45014
Otsuka Investigational Site Toledo Ohio 43560
Otsuka Investigational Site Oklahoma City Oklahoma 73120
Otsuka Investigational Site Bethleham Pennsylvania 18017
Otsuka Investigational Site Philadelphia Pennsylvania 19102
Otsuka Investigational Site Philadelphia Pennsylvania 19140
Otsuka Investigational Site West Reading Pennsylvania 19611
Otsuka Investigational Site Providence Rhode Island 02903
Otsuka Investigational Site Galveston Texas 77555
Otsuka Investigational Site Houston Texas 77030
Otsuka Investigational Site Mission Texas 78572
Otsuka Investigational Site San Antonio Texas 78205
Otsuka Investigational Site San Antonio Texas 78229
Otsuka Investigational Site Fairfax Virginia 22030
Otsuka Investigational Site Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01227512, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01227512 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →